Search results for “Iduronate Sulfatase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 109 patents, we discovered top 18 key players by total patent application. Shire Human Genetic Therapies, Inc., RegenxBio, Inc., Takeda Pharmaceutical Co., Ltd. are dominant in this area. They take 52.29% of the total patent filing.
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 30
RegenxBio, Inc.
United States
Patent: 15
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 12
Green Cross Corp.
South Korea
Patent: 11
MEDIGENEBIO CORP
United States
Patent: 11
ArmaGen, Inc.
California, United States
Patent: 8
JCR Pharmaceuticals Co., Ltd.
Hokkaido, Japan
Patent: 7
biOasis Technologies, Inc.
Connecticut, United States
Patent: 7
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 3
Angiochem, Inc.
Quebec, Canada
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Capsida Biotherapeutics, Inc.
California, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 67 patents applied in the last 5 years. We discover 20 most active companies in this area. The fast-growing RegenxBio, Inc., Takeda Pharmaceutical Co., Ltd., ArmaGen, Inc. take 47.76% of patent filing during this period.
RegenxBio, Inc.
United States
Patent: 14
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 11
ArmaGen, Inc.
California, United States
Patent: 7
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 7
MEDIGENEBIO CORP
United States
Patent: 7
Green Cross Corp.
South Korea
Patent: 6
The University of Manchester
Manchester, United Kingdom
Patent: 4
JCR Pharmaceuticals Co., Ltd.
Hokkaido, Japan
Patent: 3
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 3
biOasis Technologies, Inc.
Connecticut, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 67 patents in last 5 years, we discover 11 new entrants. The University of Manchester, Hanmi Pharmaceutical Co., Ltd., Capsida Biotherapeutics, Inc. are the most active new entrants in this area.
The University of Manchester
Manchester, United Kingdom
Patent: 4
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 3
STARTUP
Capsida Biotherapeutics, Inc.
California, United States
Patent: 2
Harbin Medical University
Heilongjiang Sheng, China
Patent: 1
Shimazu KK
Kagoshima-ken, Japan
Patent: 1
Denali Therapeutics, Inc.
California, United States
Patent: 1
Green Cross Co., Ltd.
Fukuoka-ken, Japan
Patent: 1
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 1
Shimane University
Shimane-ken, Japan
Patent: 1
University of Washington Center for Commercialization
Washington, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 7 universities and scientific research institutions by total patent application. The University of Manchester, University of Minnesota, The University of North Carolina at Chapel Hill are dominant in this area. They take 53.85% of the total patent filing.
The University of Manchester
Manchester, United Kingdom
Patent: 4
University of Minnesota
Minnesota, United States
Patent: 2
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 1
Harbin Medical University
Heilongjiang Sheng, China
Patent: 1
Shimane University
Shimane-ken, Japan
Patent: 1
Autonomous University of Barcelona
Spain
Patent: 1
Kumamoto University
Kumamoto-ken, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: